JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5151
Ampco-Pittsburgh
AP
$200M
| $0 | ﹤0.01% |
+5
| New | +$16 |
2020 Q2
0 quarters
|
|
|
BNBX
5152
DELISTED
BNB PLUS CORP
BNBX
| – | – |
0
| – | – |
2020 Q2
0 quarters
|
|
5153
PUT
Apollo Global Management
APO
$67.3B
| – | – |
-24,500
| Closed | -$821K | – |
|
5154
Aptevo Therapeutics
APVO
$3.19M
| – | – |
0
| – | – |
2017 Q2
12 quarters
|
|
5155
AquaBounty Technologies
AQB
$4.76M
| $0 | ﹤0.01% |
+1
| New | +$46 |
2020 Q2
0 quarters
|
|
|
ARDC
5156
Are Dynamic Credit Allocation Fund
ARDC
$275M
| – | – |
-3,218
| Closed | -$35K | – |
|
5157
argenx
ARGX
$57.5B
| – | – |
-3,109
| Closed | -$410K | – |
|
5158
Ark Restaurants
ARKR
$16.2M
| $0 | ﹤0.01% |
+1
| New | +$12 |
2020 Q2
0 quarters
|
|
5159
Armata Pharmaceuticals
ARMP
$131M
| $0 | ﹤0.01% |
+9
| New | +$31 |
2020 Q2
0 quarters
|
|
|
ASRT
5160
DELISTED
Assertio
ASRT
| $0 | ﹤0.01% |
1
-392
| -100% | -$20.2K |
2015 Q4
18 quarters
|
|
5161
AmeriServ Financial
ASRV
$78.8M
| $0 | ﹤0.01% |
+11
| New | +$32 |
2020 Q2
0 quarters
|
|
5162
Aterian
ATER
$11.8M
| – | – |
-12,782
| Closed | -$618K | – |
|
|
ATHE
5163
Alterity Therapeutics
ATHE
$62.8M
| – | – |
-10
| Closed | – | – |
|
|
AVDL
5164
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| – | – |
-30,000
| Closed | -$238K | – |
|
5165
Aware
AWRE
$24M
| $0 | ﹤0.01% |
+10
| New | +$30 |
2020 Q2
0 quarters
|
|
5166
AMREP Corp
AXR
$115M
| $0 | ﹤0.01% |
+1
| New | +$4 |
2020 Q2
0 quarters
|
|
5167
CALL
Axsome Therapeutics
AXSM
$9.39B
| – | – |
-50,000
| Closed | -$2.94M | – |
|
|
5168
PUT
Axsome Therapeutics
AXSM
$9.39B
| – | – |
-50,000
| Closed | -$2.94M | – |
|
|
AZUL
5169
DELISTED
Azul
AZUL
| – | – |
-18,542
| Closed | -$178K | – |
|
|
BANX
5170
ArrowMark Financial
BANX
$194M
| – | – |
-5,155
| Closed | -$83K | – |
|
5171
Innovator US Equity Buffer ETF August
BAUG
$272M
| – | – |
-4,069
| Closed | -$93K | – |
|
5172
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.41B
| – | – |
-27,913
| Closed | -$1.29M | – |
|
5173
Build-A-Bear
BBW
$315M
| $0 | ﹤0.01% |
+9
| New | +$19 |
2020 Q2
0 quarters
|
|
5174
PUT
Bath & Body Works
BBWI
$3.24B
| – | – |
-154,625
| Closed | -$1.45M | – |
|
5175
Beam Global
BEEM
$25.6M
| $0 | ﹤0.01% |
+2
| New | +$16 |
2020 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.